RFP Financial Group’s Bristol-Myers Squibb BMY Stock Holding History

RFP Financial Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,317	Closed	-$54.7K	–	193
2024 Q2	$54.7K	Buy	1,317 +296	+29%	+$13.2K	0.02%	218
2024 Q1	$55.4K	Sell	1,021 -977	-49%	-$49.8K	0.02%	196
2023 Q4	$102K	Hold	1,998	–	–	0.04%	141
2023 Q3	$116K	Sell	1,998 -660	-25%	-$40.4K	0.05%	122
2023 Q2	$170K	Buy	2,658 +2,150	+423%	+$144K	0.07%	106
2023 Q1	$35.2K	Sell	508 -2,150	-81%	-$152K	0.04%	136
2022 Q4	$191K	Buy	+2,658	New	+$200K	0.09%	94

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

RFP Financial Group's BMY Position: Q3 2024 in Review

RFP Financial Group sold out of Bristol-Myers Squibb (BMY) in Q3 2024, closing a stake of 1,317 shares — an estimated $54.7K sold.

RFP Financial Group first reported a position in BMY in Q4 2022 and held it in 7 quarters. The position peaked at $191K in Q4 2022. 2,265 funds tracked by Wall St. Rank hold BMY as of Q3 2024.

RFP Financial Group reported no remaining Bristol-Myers Squibb position as of Q3 2024 after selling out during the quarter.
RFP Financial Group sold 1,317 Bristol-Myers Squibb shares in Q3 2024, an estimated $54.7K.
RFP Financial Group first reported a position in Bristol-Myers Squibb in Q4 2022 and held it in 7 quarters.
RFP Financial Group's Bristol-Myers Squibb position peaked at $191K in Q4 2022.
2,265 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2024.

Based on RFP Financial Group's 13F filing for Q3 2024, filed 21 Oct 2024.